6-31864685-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025257.3(SLC44A4):c.1978G>A(p.Gly660Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_025257.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC44A4 | NM_025257.3 | c.1978G>A | p.Gly660Ser | missense_variant | 20/21 | ENST00000229729.11 | NP_079533.2 | |
SLC44A4 | NM_001178044.2 | c.1852G>A | p.Gly618Ser | missense_variant | 19/20 | NP_001171515.1 | ||
SLC44A4 | NM_001178045.2 | c.1750G>A | p.Gly584Ser | missense_variant | 20/21 | NP_001171516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC44A4 | ENST00000229729.11 | c.1978G>A | p.Gly660Ser | missense_variant | 20/21 | 1 | NM_025257.3 | ENSP00000229729.6 | ||
SLC44A4 | ENST00000375562.8 | c.1852G>A | p.Gly618Ser | missense_variant | 19/20 | 2 | ENSP00000364712.4 | |||
SLC44A4 | ENST00000544672.5 | c.1750G>A | p.Gly584Ser | missense_variant | 20/21 | 2 | ENSP00000444109.1 | |||
SLC44A4 | ENST00000487680.1 | n.-5G>A | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151854Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 28AN: 250894Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135674
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461884Hom.: 0 Cov.: 34 AF XY: 0.0000770 AC XY: 56AN XY: 727244
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151854Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74156
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2023 | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC44A4 protein function. This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 660 of the SLC44A4 protein (p.Gly660Ser). This variant is present in population databases (rs371751994, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SLC44A4-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at